Alexander H Shannon1, Mahendra D Chordia2, Michael D Spinosa1, Gang Su3, Zachary Ladd3, Dongfeng Pan2, Gilbert R Upchurch3, Ashish K Sharma4. 1. Department of Surgery, University of Virginia, Charlottesville, Virginia. 2. Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, Virginia. 3. Department of Surgery, University of Florida, Gainesville, Florida. 4. Department of Surgery, University of Florida, Gainesville, Florida. Electronic address: ashish.sharma@surgery.ufl.edu.
Abstract
BACKGROUND: Our previous studies showed that neutrophil infiltration and activation plays an important role in the pathogenesis of abdominal aortic aneurysms (AAA). However, there is a lack of noninvasive, inflammatory cell-specific molecular imaging methods to provide early diagnosis of AAA formation. Formyl peptide receptor 1 (FPR1) is rapidly upregulated on neutrophils during inflammation. Therefore, it is hypothesized that the use of cinnamoyl-F-(D)L-F-(D)L-F-K (cFLFLF), a PEGylated peptide ligand that binds FPR1 on activated neutrophils, would permit accurate and noninvasive diagnosis of AAA via single-photon emission computed tomography (SPECT) imaging. MATERIALS AND METHODS: Male C57BL/6 (wild-type) mice were treated with topical elastase (0.4 U/mL type 1 porcine pancreatic elastase) or heat-inactivated elastase (control), and aortic diameter was measured by video micrometry. Comparative histology was performed on Day 14 to assess neutrophil infiltration in aortic tissue. We performed near-infrared fluorescence imaging using c-FLFLF-Cy7 probe on Days 7 and 14 postelastase treatment and measured fluorescence intensity ex vivo in excised aortic tissue. A separate group of animals were injected with 99mTc-c-FLFLF 2 h before SPECT imaging on Day 14 using a SPECT/computed tomography/positron emission tomography trimodal scanner. Coexpression of neutrophils with c-FLFLF was also performed on aortic tissue by immunostaining on Day 14. RESULTS: Aortic diameter was significantly increased in the elastase group compared with controls on Days 7 and 14. Simultaneously, a marked increase in neutrophil infiltration and elastin degradation as well as decrease in smooth muscle integrity were observed in aortic tissue after elastase treatment compared with controls. Moreover, a significant increase in fluorescence intensity of c-FLFLF-Cy7 imaging probe was also observed in elastase-treated mice on Day 7 (approximately twofold increase) and Day 14 (approximately 2.5-fold increase) compared with respective controls. SPECT imaging demonstrated a multifold increase in signal intensity for 99mTc-cFLFLF radiolabel probe in mice with AAA compared with controls on Day 14. Immunostaining of aortic tissue with c-FLFLF-Cy5 demonstrated a marked increase in coexpression with neutrophils in AAA compared with controls. CONCLUSIONS: cFLFLF, a novel FPR1 ligand, enables quantifiable, noninvasive diagnosis and progression of AAAs. Clinical application of this inflammatory, cell-specific molecular probe using SPECT imaging may permit early diagnosis of AAA formation, enabling targeted therapeutic interventions and preventing impending aortic rupture.
BACKGROUND: Our previous studies showed that neutrophil infiltration and activation plays an important role in the pathogenesis of abdominal aortic aneurysms (AAA). However, there is a lack of noninvasive, inflammatory cell-specific molecular imaging methods to provide early diagnosis of AAA formation. Formyl peptide receptor 1 (FPR1) is rapidly upregulated on neutrophils during inflammation. Therefore, it is hypothesized that the use of cinnamoyl-F-(D)L-F-(D)L-F-K (cFLFLF), a PEGylated peptide ligand that binds FPR1 on activated neutrophils, would permit accurate and noninvasive diagnosis of AAA via single-photon emission computed tomography (SPECT) imaging. MATERIALS AND METHODS: Male C57BL/6 (wild-type) mice were treated with topical elastase (0.4 U/mL type 1 porcine pancreatic elastase) or heat-inactivated elastase (control), and aortic diameter was measured by video micrometry. Comparative histology was performed on Day 14 to assess neutrophil infiltration in aortic tissue. We performed near-infrared fluorescence imaging using c-FLFLF-Cy7 probe on Days 7 and 14 postelastase treatment and measured fluorescence intensity ex vivo in excised aortic tissue. A separate group of animals were injected with 99mTc-c-FLFLF 2 h before SPECT imaging on Day 14 using a SPECT/computed tomography/positron emission tomography trimodal scanner. Coexpression of neutrophils with c-FLFLF was also performed on aortic tissue by immunostaining on Day 14. RESULTS: Aortic diameter was significantly increased in the elastase group compared with controls on Days 7 and 14. Simultaneously, a marked increase in neutrophil infiltration and elastin degradation as well as decrease in smooth muscle integrity were observed in aortic tissue after elastase treatment compared with controls. Moreover, a significant increase in fluorescence intensity of c-FLFLF-Cy7 imaging probe was also observed in elastase-treated mice on Day 7 (approximately twofold increase) and Day 14 (approximately 2.5-fold increase) compared with respective controls. SPECT imaging demonstrated a multifold increase in signal intensity for 99mTc-cFLFLF radiolabel probe in mice with AAA compared with controls on Day 14. Immunostaining of aortic tissue with c-FLFLF-Cy5 demonstrated a marked increase in coexpression with neutrophils in AAA compared with controls. CONCLUSIONS:cFLFLF, a novel FPR1 ligand, enables quantifiable, noninvasive diagnosis and progression of AAAs. Clinical application of this inflammatory, cell-specific molecular probe using SPECT imaging may permit early diagnosis of AAA formation, enabling targeted therapeutic interventions and preventing impending aortic rupture.
Authors: Jonathan L Eliason; Kevin K Hannawa; Gorav Ailawadi; Indranil Sinha; John W Ford; Michael P Deogracias; Karen J Roelofs; Derek T Woodrum; Terri L Ennis; Peter K Henke; James C Stanley; Robert W Thompson; Gilbert R Upchurch Journal: Circulation Date: 2005-07-12 Impact factor: 29.690
Authors: Eric J Charles; Mahendra D Chordia; Yunge Zhao; Yi Zhang; J Hunter Mehaffey; David K Glover; Julien Dimastromatteo; W Zachary Chancellor; Ashish K Sharma; Irving L Kron; Dongfeng Pan; Victor E Laubach Journal: Am J Physiol Lung Cell Mol Physiol Date: 2019-12-04 Impact factor: 5.464
Authors: David C Brewster; Jack L Cronenwett; John W Hallett; K Wayne Johnston; William C Krupski; Jon S Matsumura Journal: J Vasc Surg Date: 2003-05 Impact factor: 4.268
Authors: Anna Z Fashandi; Robert B Hawkins; Morgan D Salmon; Michael D Spinosa; William G Montgomery; J Michael Cullen; Guanyi Lu; Gang Su; Gorav Ailawadi; Gilbert R Upchurch Journal: Surgery Date: 2017-11-28 Impact factor: 3.982
Authors: T Freestone; R J Turner; A Coady; D J Higman; R M Greenhalgh; J T Powell Journal: Arterioscler Thromb Vasc Biol Date: 1995-08 Impact factor: 8.311
Authors: Aneesh K Ramaswamy; Mark Hamilton; Rucha V Joshi; Benjamin P Kline; Rui Li; Pu Wang; Craig J Goergen Journal: ScientificWorldJournal Date: 2013-04-23
Authors: Michael D Spinosa; William G Montgomery; Melissa Lempicki; Prasad Srikakulapu; Matthew J Johnsrude; Coleen A McNamara; Gilbert R Upchurch; Gorav Ailawadi; Norbert Leitinger; Akshaya K Meher Journal: Am J Pathol Date: 2021-09-09 Impact factor: 4.307
Authors: Vinamr Rastogi; Sanne J M Stefens; Judith Houwaart; Hence J M Verhagen; Jorg L de Bruin; Ingrid van der Pluijm; Jeroen Essers Journal: Front Med (Lausanne) Date: 2022-04-15
Authors: Joshua T Mattila; Wissam Beaino; Alexander G White; Lea Nyiranshuti; Pauline Maiello; Jaime Tomko; L James Frye; Daniel Fillmore; Charles A Scanga; Philana Ling Lin; JoAnne L Flynn; Carolyn J Anderson Journal: ACS Infect Dis Date: 2021-07-13 Impact factor: 5.578